Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christian Eickmeier is active.

Publication


Featured researches published by Christian Eickmeier.


Bioorganic & Medicinal Chemistry Letters | 2010

An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction

Stephen Peter East; Samantha Jayne Bamford; Matthias G.A. Dietz; Christian Eickmeier; Adam Flegg; Boris Ferger; Mark J. Gemkow; Ralf Heilker; Bastian Hengerer; Adrian Kotei Kotey; Pui Loke; Gerhard Schänzle; Hans-Dieter Schubert; John Scott; Mark Whittaker; Mildred Williams; Przemyslaw Zawadzki; Kai Gerlach

A high-throughput screening campaign identified 4-((E)-styryl)-pyrimidin-2-ylamine (11) as a positive allosteric modulator of the metabotropic glutamate (mGlu) receptor subtype 4. An evaluation of the structure-activity relationships (SAR) of 11 is described and the efficacy of this compound in a haloperidol-induced catalepsy rat model following oral administration is presented.


Journal of Neurotrauma | 2003

Differential Effects of Immunophilin-Ligands (FK506 and V-10,367) on Survival and Regeneration of Rat Retinal Ganglion Cells In Vitro and after Optic Nerve Crush In Vivo

Philip Rosenstiel; Peter Schramm; Stefan Isenmann; Stefan Brecht; Christian Eickmeier; Erich Bürger; Thomas Herdegen; Jobst Sievers; Ralph Lucius

Immunophilins belong to the large family of peptidyl-prolyl-cis-trans-isomerases known to be involved in many cellular processes (e.g., protein trafficking and transcriptional regulation). Beside the widespread therapeutic use of ligands of immunophilins as immunosuppressants, it has been shown that some of these compounds such as FK506 and V-10,367 may mediate neuroprotection and improve axonal regeneration following damage to peripheral nerve fibers. Here, we have analyzed the effects of these two compounds on neurite outgrowth of retinal explants in vitro and on axonal regeneration of retinal ganglion cells, a population of central intrinsic neurons, ten days following optic nerve crush in vivo. FK506 enhanced neurite outgrowth/regrowth in vitro in a dose dependent manner up to 135% (control = 100%), while V-10,367 was more effective (up to 168%). In vivo, intravitreal V-10,367 and FK506 significantly reduced the number of dying retinal ganglion cells as demonstrated by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling. Local application of FK506 into the vitreous body, but not V-10,367, immediately provided after the optic nerve crush induced the elongation of regenerating fibers across the lesion site for around 1.2 mm. Our data provide evidence that the ligands of the FK506-binding proteins FK506 and V-10,367 protect (otherwise dying) retinal ganglion cells from optic nerve crush-induced cell death, promote neurite outgrowth in vitro and that locally applied FK506 enhances the sprouting of axotomized central intrinsic neurons such as retinal ganglion cells in vivo after optic nerve crush.


Bioorganic & Medicinal Chemistry | 2018

Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators

Kai Gerlach; Scott Hobson; Christian Eickmeier; Ulrike Groß; Clemens Braun; Peter Sieger; Michel Garneau; Stefan Hoerer; Niklas Heine

The identification and optimization of a novel series of centrally efficacious gamma secretase modulators (GSMs) offering an alternative to the privileged aryl imidazole motif is described. Chiral bicyclic tetrahydroindazolyl amine substituted triazolopyridines were identified as structurally distinct novel series of GSMs. Representative compound BI-1408 ((R)-42) was demonstrated to be centrally efficacious in rats at a 30 mg/kg oral dose.


Archive | 2003

Dihydropteridinones, method for the production and use thereof in the form of drugs

Matthias Hoffmann; Matthias Grauert; Trixi Brandl; Steffen Breitfelder; Christian Eickmeier; Martin Steegmaier; Gisela Schnapp; Anke Baum; Jens Juergen Quant; Flavio Solca; Florian Colbatzky


Archive | 2002

Novel dihydropteridinones, method for producing the same and the use thereof as medicaments

Matthias Hoffmann; Matthias Grauert; Steffen Breitfelder; Christian Eickmeier; Gerald Pohl; Thorsten Lehmann-Lintz; Norbert Redemann; Gisela Schnapp; Martin Steegmaier; Eckhart Bauer; Jens Juergen Quant


Archive | 2003

New dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions

Matthias Hoffmann; Matthias Grauert; Trixi Brandl; Steffen Breitfelder; Christian Eickmeier; Martin Steegmaier; Gisela Schnapp; Anke Baum; Jens Juergen Quant; Flavio Solca; Florian Colbatzky


American Journal of Physiology-heart and Circulatory Physiology | 2000

Na+/H+ exchange inhibition-induced cardioprotection in dogs: effects on neutrophils versus cardiomyocytes

Richard J. Gumina; John A. Auchampach; Rongang Wang; Erich Buerger; Christian Eickmeier; Jeannine Moore; Juergen Daemmgen; Garrett J. Gross


Archive | 2006

COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Klaus Fuchs; Christian Eickmeier; Niklas Heine; Stefan Peters; Cornelia Dorner-Ciossek; Sandra Handschuh; Herbert Nar; Klaus Klinder


Archive | 2004

Intermediate Compounds for making Dihydropteridinones Useful as Pharmaceutical Compositions

Matthias Hoffmann; Matthias Grauert; Trixi Brandl; Steffen Breitfelder; Christian Eickmeier; Martin Steegmaier; Gisela Schnapp; Anke Baum; Jens Jurgen Quant; Flavio Solca; Florian Colbatzky


Archive | 2004

Methods of using dihydropteridinones

Eckhart Bauer; Steffen Breitfelder; Christian Eickmeier; Matthias Grauert; Matthias Hoffmann; Thorsten Lehmann-Lintz; Gerald Phol; Jens Juergen Quant; Norbert Redemann; Gisela Schnapp; Martin Steegmaier

Collaboration


Dive into the Christian Eickmeier's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge